Evidence map›Paper›PMID 34480423›Full record

ArticleMolecular genetics & genomic medicine2021

Compound heterozygous null mutations of NOBOX in sisters with delayed puberty and primary amenorrhea.

Asma Sassi, Julie Désir, Sarah Duerinckx, Julie Soblet, Sonia Van Dooren, Maryse Bonduelle, Marc Abramowicz, Anne Delbaere

Open access · goldAbstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Association between polymorphisms inFrontiers in veterinary science · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Asma SassiFertility Clinic, Department of Obstetrics and Gynecology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.ORCID 0000-0003-0085-7824
Julie DésirDepartment of Genetics, Erasme Hospital, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium.
Sarah DuerinckxInstitute of Interdisciplinary Research in Human and Molecular Biology, Human Genetics, IRIBHM, Université Libre de Bruxelles, Brussels, Belgium.ORCID 0000-0003-2919-0664
Julie SobletDepartment of Genetics, Erasme Hospital, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium.
Sonia Van DoorenBrussels Interuniversity Genomics High Throughput core (Bright Core), Brussels, Belgium.
Maryse BonduelleCentre for Medical Genetics, Reproduction and Genetics, Reproduction and Genetics and Regenerative Medicine, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
Marc AbramowiczDepartment of Genetics, Erasme Hospital, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium.
Anne DelbaereFertility Clinic, Department of Obstetrics and Gynecology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.ORCID 0000-0001-7236-0687
Université Libre de Bruxelles · BEVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPremature ovarian insufficiency (POI) is a heterogeneous clinical syndrome defined by a premature loss of ovarian function that associates menstrual disturbances and hypergonatropic hypogonadism. POI is a major cause of female infertility affecting 1% of women before the age of 40 and up to 0.01% before the age of 20. The etiology of POI may be iatrogenic, auto-immune or genetic but remains however undetermined in a large majority of cases. An underlying genetic etiology has to be searched in idiopathic cases, particularly in the context of a family history of POI.

methodsWhole exome sequencing (WES) was performed in trio in a Belgian patient presenting POI and in her two parents. The patient presented delayed puberty and primary amenorrhea with hypergonadotropic hypogonadism.

resultsWES identified two novel compound heterozygous truncating mutations in the Newborn oogenesis homeobox (NOBOX) gene, c.826C>T (p.(Arg276Ter)) and c.1421del (p.(Gly474AlafsTer76)). Both mutations were confirmed by Sanger sequencing in the proband's sister who presented the same phenotype. Both variants were pathogenic and very likely responsible for the severe POI in this family.

conclusionWe report here for the first time compound heterozygous truncating mutations of NOBOX in outbred patients, generalizing biallelic NOBOX null mutations as a cause of severe POI with primary amenorrhea. In addition, our findings also suggest that NOBOX haploinsufficiency is tolerated.

Indexed as

HeterozygoteMutationSiblingsAdolescentAllelesAmenorrheaDNA Mutational AnalysisExome SequencingFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHomeodomain ProteinsHumansPedigreeHomeodomain ProteinsNOBOX protein, humanTranscription Factorsdelayed pubertygeneticsloss of functionnext generation sequencingNOBOX genepremature ovarian insufficiency

Identifiers

PMID34480423
PMCPMC8580073
OpenAlexW3197911434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.